This vaccine targets parts of the influenza virus that do not change much over time. London: Medical experts have completed successful human trials (Phase 2 clinical trials) of all kinds of cold-resistant “universal flu vaccine” and are now ready to take it to the next stage. It should be noted, that any new drug is first tested on animals, it's carefully tested in 15 to 30 patients and beneficial effects evaluated on these trials called “phase 1 clinical trial.” After the success, the same drug tested in about 100 patients in t…
Follow Us